Evidence map›Paper›PMID 42198599›Full record

ArticlePathogens (Basel, Switzerland)2026

A Neuronal Cell Line Model for Studying Camel Prions.

Basant Abdulrahman, Shabboo Rahimi Aqdam, Matteo Mosca, Hanaa Ahmed-Hassan, Melissa Razcon-Echeagaray, Lia Popa, Sabine Gilch, Baaissa Babelhadj, Gabriele Vaccari, Hermann M Schätzl

Abstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Basant AbdulrahmanCalgary Prion Research Unit, University of Calgary, Calgary, AB T2N 4Z6, Canada.
Shabboo Rahimi AqdamCalgary Prion Research Unit, University of Calgary, Calgary, AB T2N 4Z6, Canada.
Matteo MoscaCalgary Prion Research Unit, University of Calgary, Calgary, AB T2N 4Z6, Canada.
Hanaa Ahmed-HassanCalgary Prion Research Unit, University of Calgary, Calgary, AB T2N 4Z6, Canada.
Melissa Razcon-EcheagarayCalgary Prion Research Unit, University of Calgary, Calgary, AB T2N 4Z6, Canada.
Lia PopaCalgary Prion Research Unit, University of Calgary, Calgary, AB T2N 4Z6, Canada.
Sabine GilchCalgary Prion Research Unit, University of Calgary, Calgary, AB T2N 4Z6, Canada.ORCID 0000-0001-5923-3464
Baaissa BabelhadjDepartment of Natural Sciences, Ecole Normale Supérieure de Ouargla, Cité Ennasr, Ouargla 30000, Algeria.ORCID 0000-0003-0178-4751
Gabriele VaccariIstituto Superiore di Sanità, Department of Food Safety, Nutrition and Veterinary Public Health, 00161 Rome, Italy.ORCID 0000-0003-0215-3521
Hermann M SchätzlCalgary Prion Research Unit, University of Calgary, Calgary, AB T2N 4Z6, Canada.ORCID 0000-0003-4972-8740

Funding

Redefining the zoonotic potential of chronic wasting diseaseR01NS121016 · NINDS · UNIVERSITY OF CALGARY · PI GILCH, SABINE, SCHATZL, HERMANN M · 2021 to 2025
$1.3M
Alberta Innovates 201600009Alberta Innovates 201900008NINDS NIH HHS R01 NS121016
6 · The paper itself

Abstract

Prion diseases are fatal neurodegenerative disorders that affect humans and animals, caused by the conformational conversion of the normal cellular prion protein (PrP

Indexed as

CamelusNeuronsPrion DiseasesPrionsAnimalsBrainCell LineGene Knockout TechniquesMicePrionsCAD5 cellscamel prion diseasecell culture modelsCRISPR-Cas/9gene-editingknock-out cellsprionprion diseaseprion infection

Identifiers

PMID42198599
PMCPMC13209568

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.